What is Charles River Laboratories International, Inc.'s business focus and history?
Charles River Laboratories International, Inc. is a publicly traded company based in Wilmington, Massachusetts, founded in 1947. It operates as a contract research organization providing preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Charles River Laboratories has over 20,000 employees worldwide and has been involved in the development of over 80% of FDA-approved drugs in recent years.
Charles River Laboratories International, Inc. Corporate Details & Core Services
Charles River Laboratories International, Inc. is a leading global contract research organization (CRO) providing essential products and services to help pharmaceutical and biotechnology companies, government agencies, and academic institutions accelerate their drug discovery and development efforts.
Charles River Laboratories International, Inc. Contact Information & Official Links
Website https://www.criver.com
Social
Email id info@criver.com
Phone number +1 781-222-6000
Head office address Wilmington, Massachusetts, United States
Tags
Contract Research Organization
Preclinical Services
Drug Development
Biologics Testing
Cell and Gene Therapy
What are Charles River Laboratories International, Inc.'s Key Business Metrics & Stats?
No of employees 20000
Founded year 1947
Type public
SAICS CODE 8731
NAICS Code 541715
Industry Pharmaceuticals, Biotechnology, Gene Therapy, Cell Therapy, Medical Devices, Contract Research
Location Wilmington, Massachusetts, United States
Subsidiary Company
inveresk.com, citoxlab.com, hemacare.com, cognatebioservices.com, retrogenix.com, vigene.com
Other website criver.com
Pricing Strategy Standard retail pricing for consumers, Bulk pricing for wholesale partners, Custom quotes for corporate clients
Charles River Laboratories International, Inc.
Firmographic Snapshot
2026
1947
Founded Year
20000
Global Employees
United States
Headquarters
Pharmaceuticals, Biotechnology, Gene Therapy, Cell Therapy, Medical Devices, Contract Research Industry
Public
Type
Verified by
DexterAgent.ai
How much funding has Charles River Laboratories International, Inc. raised to date?
Name
Description
Latest Valuation
(USD)
What are Charles River Laboratories International, Inc.'s Core Products?
Name
Description
New Englander® Rain Jacket
Weatherproof protection with timeless New England style, made for the whole family.
Camden Crew
Soft, versatile, and made to live in.
Franconia Quilted Jacket - Patriots Edition
Exclusive, limited-edition quilted jacket co-designed with the New England Patriots.
Crosswind Quarter Zip Sweatshirt - Patriots Edition
Limited-edition quarter zip sweatshirt featuring New England Patriots branding.
Pack-N-Go® Pullover - Patriots Edition
Lightweight, packable pullover with New England Patriots design.
Lexington Stretch Full Zip Jacket
Full zip jacket offering comfort and flexibility for everyday wear.
Hyannis Snap Shacket
A versatile snap-front shirt-jacket hybrid for layering.
What are the latest developments at Charles River Laboratories International, Inc.?
Date
Type
Description
February, 2025
Financial Update
Announced fourth-quarter and full-year 2024 results, providing 2025 guidance.
May, 2025
Financial Update
Reported first-quarter 2025 results, increasing 2025 guidance.
August, 2025
Financial Update
Announced second-quarter 2025 results, updating 2025 guidance.
November, 2025
Strategic Review
Provided update on strategic review, announcing steps to strengthen and refine portfolio.
November, 2025
Legal Update
SEC investigation concluded with no enforcement action.
What industry awards and recognitions has Charles River Laboratories International, Inc. received?
Date
Type
Description
March, 2025
Industry Recognition
Received 2025 CDMO Leadership Award from Outsourced Pharma.
October, 2023
Environmental Achievement
Achieved 90% renewable electricity globally, recognized by Energy Star.
Charles River Laboratories International, Inc. VS IQVIA VS PPD VS Syneos Health VS Parexel VS Covance : 2026 Comparison
Feature
Charles River Laboratories International, Inc.
IQVIA
PPD
Syneos Health
Parexel
Covance
Core Strengths New Englander® Rain Jacket, Camden Crew, Franconia Quilted Jacket - Patriots Edition, Crosswind Quarter Zip Sweatshirt - Patriots Edition, Pack-N-Go® Pullover - Patriots Edition, Lexington Stretch Full Zip Jacket, Hyannis Snap Shacket
IQVIA CORE, IQVIA Connected Intelligence
Clinical Development Services, Laboratory Services, Functional Service Partnerships
Clinical Development Services, Commercial Delivery, Consulting
Clinical Trial Management, Regulatory Consulting, Real World Evidence, Medical Communications
Xcellerate Monitoring
Founded Year 1947
2016
1985
2017
1982
1968
Stock Name/Ticker IQV (NYSE)
LH (NYSE)
Type public
public
private
private
private
public
Global Employees 20000
88000
40000
29000
24000
15500
Revenue (Annual) $4.1 Billion(2024)
$15.4 Billion(2024)
$4.7 Billion(2020)
$5.4 Billion(2022)
$2.3 Billion(2017)
$8.5 Billion(2014)
Headquarters Wilmington, Massachusetts, United States
Durham, North Carolina, United States
Waltham, Massachusetts, United States
Morrisville, North Carolina, United States
Raleigh, North Carolina, United States
Durham, North Carolina, United States
Latest Valuation
$15.4 Billion
$17.4 Billion
$7.1 Billion
$8.5 Billion
$0
LATEST REVENUE (TRILLIONS USD)
EMPLOYEE COUNT (THOUSANDS)
INNOVATORS
VISIONARIES
DISRUPTORS
GIANTS
IQVIA
15.4 | 88000
PPD
4.7 | 40000
Syneos Health
5.4 | 29000
Parexel
2.3 | 24000
Competitive Landscape 2026
DexterAgent.ai
What are Charles River Laboratories International, Inc.'s official legal and registration details?
Name
Description
Legal Name
Charles River Laboratories International, Inc.
Cin number
GST number
Registration number
1598641074
Who is in Charles River Laboratories International, Inc.'s executive leadership team?
Name
Designation
CEO
Jason Lipsett
Founder
Barry Lipsett
Where are Charles River Laboratories International, Inc.'s primary office locations?
City
Country
Wilmington
United States
Edinburgh
United Kingdom
Shanghai
China
Montreal
Canada
Tokyo
Japan
What are the current business signals and market intelligence for Charles River Laboratories International, Inc.?
Spending next 3 months
Expanding direct-to-consumer sales channels, Enhancing online retail platform, Developing new product lines
Pain points
Transitioning from B2B to B2C sales model, Building brand awareness among consumers, Managing inventory for direct sales
Sales motion
Direct-to-consumer online sales, Collaborations with sports teams, Wholesale distribution to retailers
Buyer Persona
Sports enthusiasts, Fashion-conscious individuals, Corporate clients seeking branded apparel
Type of customer
Individual consumers, Retail partners, Corporate clients
Key customer domain
Apparel and fashion, Sports merchandise, Corporate branding
Annual ACV
Individual consumers: $100-$200, Retail partners: $10,000-$50,000, Corporate clients: $5,000-$20,000
What is Charles River Laboratories International, Inc.'s annual revenue history?
Year
Revenue (USD)
2024
4.1 Billion
2023
4.1 Billion
2022
4 Billion
2021
3.5 Billion
2020
2.9 Billion
What are Charles River Laboratories International, Inc.'s risk management and compliance ratings?
GDPR RIsk
No
Privacy Risk
No
Company Ratings
3.1
Glassdoor Rating
3.1
Saas
No
Offline Stores
No
Service
No
Ecommerce
No
Exporter
No
Mobile App
No
Retail
No
B2B
No
B2C
No
Manufacturing
No
Wholesale
No
Importer
No
